相关实验视频
Updated: Jun 17, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.5K
除了2型喘生物标志物之外:对NSAID加剧的呼吸道疾病的风险分层
Jacqueline Pérez-Pazos1,2, Asunción García-Sánchez1,3,4, Miguel Estravís1,3
1Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
ERJ open research
|August 6, 2024
概括
与健康个体相比,2型喘患者表现出不同的基因表达模式. 像ALOX15,SMPD3和CLC这样的特定基因可以作为诊断T2喘及其亚型的生物标志物.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
背景情况:
- 2型 (T2) 喘经常同时发生慢性鼻炎与鼻多重症 (CRSwNP) 和非类固醇抗炎药物加剧性呼吸道疾病 (N-ERD).
- 之前在没有CRSwNP的T2喘中进行的转录基因研究发现了差异表达的基因,促使对特定基因进行进一步调查.
- 基因ALOX15,CLC,CYSLTR2,HRH4和SMPD3因其在T2喘病原发生中的潜在作用而被选择.
研究的目的:
- 验证先前在T2喘患者中与并发症或没有并发症中识别的差异性表达基因.
- 研究这些基因在不同T2喘层 (喘,喘与CRSwNP,N-ERD) 的关联模式.
- 确定T2喘诊断和风险分层的潜在基因表达生物标志物,特别是N-ERD.
主要方法:
- 从103名T2喘患者和100名健康对照患者的血液衍生RNA样本进行定量PCR分析.
- 对T2喘患者的分层分为仅喘,有CRSwNP喘和N-ERD组.
- 统计分析以确定差异表达的基因及其与临床表型的关联.
主要成果:
- 所有T2喘患者组与健康对照组相比,研究基因的表达显著更高.
- 观察到不同的基因表达模式:非并发症中的ALOX15,并发症组中的SMPD3和CLC,以及所有患者组中的HRH4.
- ALOX15,CYSLTR2和SMPD3显示出作为T2喘诊断的生物标志物的潜力,特别是在与外周血液中乙氨基酸细胞计数相结合时. CLC 和 CYSLTR2 特别涉及到 N-ERD.
结论:
- 该研究验证了T2喘中差异表达的关键基因,揭示了不同患者层中的独特分子特征.
- 特定的基因表达模式表明独特的潜在分子机制有助于T2喘谱.
- 鉴定的基因,特别是SMPD3,作为T2喘和N-ERD的诊断和预后生物标志物具有前途,可能有助于治疗分层.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69
Drugs Used in Lower Respiratory Disorders: Overview
383
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
383
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K

